TickerFactsScreenerDevelopers

CORCEPT THERAPEUTICS INC (CORT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$17.97M2010: -$22.29M2011: -$27.40M2012: -$36.02M2013: -$37.06M2016: $18.39M2017: $60.94M2018: $115.67M2019: $136.12M2020: $151.97M2021: $167.89M2022: $120.32M2023: $126.68M2024: $198.29M2025: $142.00M$142.00M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$142.00M-28.4%
2024$198.29M+56.5%
2023$126.68M+5.3%
2022$120.32M-28.3%
2021$167.89M+10.5%
2020$151.97M+11.6%
2019$136.12M+17.7%
2018$115.67M+89.8%
2017$60.94M+231.3%
2016$18.39M—
2013-$37.06M-2.9%
2012-$36.02M-31.5%
2011-$27.40M-23.0%
2010-$22.29M-24.0%
2009-$17.97M—